Michael N Koss
Overview
Explore the profile of Michael N Koss including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
1183
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wei C, Baratelli F, Xiao G, Koss M, Elatre W
Appl Immunohistochem Mol Morphol
. 2018 Aug;
27(2):e11-e15.
PMID: 30095465
Background: Distinction of idiopathic pulmonary fibrosis (IPF) from other chronic fibrosing interstitial pneumonitides, such as hypersensitivity pneumonitis (HP) and connective tissue diseases, is critical due to varied biological and clinical...
2.
Zhou B, Flodby P, Luo J, Castillo D, Liu Y, Yu F, et al.
J Clin Invest
. 2018 Feb;
128(3):970-984.
PMID: 29400695
Claudins, the integral tight junction (TJ) proteins that regulate paracellular permeability and cell polarity, are frequently dysregulated in cancer; however, their role in neoplastic progression is unclear. Here, we demonstrated...
3.
Gelb A, Yamamoto A, Verbeken E, Schein M, Moridzadeh R, Tran D, et al.
Chest
. 2017 Dec;
153(3):618-629.
PMID: 29197547
Background: Previously, we and other investigators have described reversible loss of lung elastic recoil in patients with acute and persistent, moderate-to-severe, chronic, treated asthma who never smoked, and its adverse...
4.
Koss M
Methods Mol Biol
. 2014 Jul;
1180:323-36.
PMID: 25015157
Renal biopsy is the gold standard for diagnosis of kidney disease; indeed, it allows for determination of the type, extent, site, and nature of renal involvement in medical diseases, and...
5.
Shigemitsu H, Orjioke N, Shriki J, Varras J, Koss M
Chest
. 2014 Feb;
145(2):407-410.
PMID: 24493514
No abstract available.
6.
Guinee Jr D, Franks T, Gerbino A, Murakami S, Acree S, Koss M
Am J Surg Pathol
. 2013 Apr;
37(5):699-709.
PMID: 23588364
On the basis of an initial case, we hypothesized that IgG4-positive plasma cells may be increased in pulmonary nodular lymphoid hyperplasia (PNLH) compared with other lymphoid proliferations of the lung....
7.
Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression
Selamat S, Chung B, Girard L, Zhang W, Zhang Y, Campan M, et al.
Genome Res
. 2012 May;
22(7):1197-211.
PMID: 22613842
Lung cancer is the leading cause of cancer death worldwide, and adenocarcinoma is its most common histological subtype. Clinical and molecular evidence indicates that lung adenocarcinoma is a heterogeneous disease,...
8.
Barbers R, Papanikolaou I, Koss M, Patel A, Katagihara E, Arenas M, et al.
Pulm Med
. 2012 Mar;
2012:829608.
PMID: 22448330
Background. Inflammation and remodeling are integral parts of asthma pathophysiology. We sought to describe the clinical and pathologic features of near fatal asthma exacerbation (NFE). Methods. Bronchial biopsies were collected...
9.
Jacob N, Guo S, Mathian A, Koss M, Gindea S, Putterman C, et al.
J Immunol
. 2011 Mar;
186(8):4984-93.
PMID: 21383240
IFN-α is a potent activator of innate and adaptive immunity, and its administration to preautoimmune (NZB×NZW)F1 mice promotes virulent systemic lupus erythematosus (SLE) disease. Given the known contributions of B...
10.
Agrawal H, Jacob N, Carreras E, Bajana S, Putterman C, Turner S, et al.
J Immunol
. 2009 Oct;
183(9):6021-9.
PMID: 19812195
Type I IFNs are potent regulators of innate and adaptive immunity and are implicated in the pathogenesis of systemic lupus erythematosus. Here we report that clinical and pathological lupus nephritis...